首页|期刊导航|国际肝胆胰疾病杂志（英文版）|Conversion therapy in liver transplantation for hepatocellular carcinoma:What's new in the era of molecular and immune therapy?

Conversion therapy in liver transplantation for hepatocellular carcinoma:What's new in the era of molecular and immune therapy?

Chao Jiang Xiao-Dong Sun Wei Qiu Yu-Guo Chen Da-Wei Sun Guo-Yue Lv

国际肝胆胰疾病杂志（英文版）2023，Vol.22Issue(1)：7-13,7.

Conversion therapy in liver transplantation for hepatocellular carcinoma:What's new in the era of molecular and immune therapy?

Chao Jiang ¹Xiao-Dong Sun ¹Wei Qiu ¹Yu-Guo Chen ¹Da-Wei Sun ¹Guo-Yue Lv¹

作者信息

1. General Surgery Center,Department of Hepatobiliary and Pancreatic Surgery,the First Hospital of Jilin University,Changchun 130021,China
折叠

摘要

关键词

Liver transplantation/Hepatocellular carcinoma/Conversion therapy/Targeted therapy/Immunotherapy/Combination therapy

Key words

Liver transplantation/Hepatocellular carcinoma/Conversion therapy/Targeted therapy/Immunotherapy/Combination therapy

引用本文复制引用

Chao Jiang,Xiao-Dong Sun,Wei Qiu,Yu-Guo Chen,Da-Wei Sun,Guo-Yue Lv..Conversion therapy in liver transplantation for hepatocellular carcinoma:What's new in the era of molecular and immune therapy?[J].国际肝胆胰疾病杂志（英文版）,2023,22(1):7-13,7.

基金项目

This study was supported by grants from the National Natural Science Foundation of China(U20A20360),the National Key R&D Program of China(2018YFC1312102),the Development and Reform Commission of Jilin Province(2014G074),and the Jilin Provincial Department of Finance(JLSWSRCZX2021-016). （U20A20360）

国际肝胆胰疾病杂志（英文版）

OACSCD

ISSN：1499-3872

访问量0

下载量0

段落导航